Article

Stratification of COVID-19 severity using SeptiCyte RAPID, a novel host immune response…

medRxiv: the preprint server for health sciences · 2022 · Victor Gravrand, author François Mellot, author Felix Ackermann, author Marie-Christine Ballester, author Benjamin Zuber, author James T. Kirk, author Krupa Navalkar, author Thomas D. Yager, author Fabien Petit, author Tiffany Pascreau, author Eric Farfour, author Marc Vasse, author

Key facts

Title Stratification of COVID-19 severity using SeptiCyte RAPID, a novel host immune response test
First author Victor Gravrand, author François Mellot, author Felix Ackermann, author Marie-Christine Ballester, author Benjamin Zuber, author James T. Kirk, author Krupa Navalkar, author Thomas D. Yager, author Fabien Petit, author Tiffany Pascreau, author Eric Farfour, author Marc Vasse, author
Journal medRxiv : the preprint server for health sciences
Published Sep 21, 2022
DOI 10.1101/2022.09.15.22279735
Devices mentioned 010423, BP090080, DEN070004, K000945, K013842, K020469, K051564, K060540, K063329, K070462, K080837, K082118 and 74 more
Product codes mentioned CDD, CDQ, CDT, CDZ, CEK, CEO, CEW, CFJ, CFP, CFR, CGS, CGX and 120 more

At a glance

  • 10–99 FDA submissions mentioned
  • 100–999 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature